Clinical Trial Study Phase 2

MiMedx Files With The FDA To Initiate The Company’s Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee

MARIETTA, Ga., Sept. 19, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics…